Activation of Anti-Leukemia Immunity by Targeting Protein Arginine Methyltransferase |
City of Hope National Medical Center / Ling Li, PhD |
R Accelerated Award Grants |
2023 |
California |
Empowering specificity of AML immunotherapies by HSC engineering |
Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Pietro Genovese |
Catalyst Grants |
2023 |
Georgia |
Empowering specificity of AML immunotherapies by HSC engineering |
Boston Children’s Hospital / Pietro Genovese |
Catalyst Grants |
2023 |
Massachusetts |
Circumventing Pediatric Solid Tumor Microenvironment Resistance by Combinatorial CAR NK and Immunomodulating Therapy |
New York Medical College / Mitchell Cairo, MD |
Reach Grants |
2023 |
New York |
Reversing Feedback Immunosuppression during Oncolytic Virotherapy of Pediatric High Grade Glioma |
Augusta University Research Institute, Inc. / Bangxing Hong, PhD |
Reach Grants |
2023 |
Georgia |
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine / Leidy Diana Caraballo Galva, PhD |
Young Investigator Grants |
2023 |
Texas |
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus / Catherine Danis, PhD |
Young Investigator Grants |
2023 |
Colorado |